Additionally, patients experienced modest weight loss averaging 2 to 3 kg over 6 months, an unexpected but welcome effect that distinguished GLP-1 receptor agonists from many other diabetes medications that cause weight gain
MLP is also backed by 2 human clinical research trials demonstrating cognitive benefits
If youre unfamiliar with that drug, marketed as Bydureon (exenatide) Pen by AstraZeneca, thats because it was discontinued in 2021 due to business reasons. Could it also have something to do with the next generation of GLP-1s being even better
There is also a connection between mast cells and the thyroid
The most common type of hair loss noted in cirrhosis population is telogen effluvium, a noninflammatory alopecia, impacts the entire scalp and can be triggered by stress, illness, pregnancy, malnutrition, infections, endocrine disorders, surgeries, and certain medications
22nd ed